FibroBiologics
Logotype for FibroBiologics Inc

FibroBiologics (FBLG) investor relations material

FibroBiologics Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for FibroBiologics Inc
Q4 2025 earnings summary24 Feb, 2026

Executive summary

  • Secured HREC approvals in Australia for a Phase 1/2 trial of CYWC628 in diabetic foot ulcers, enabling enrollment of 120 patients at up to 10 sites.

  • Filed IND with FDA for CYPS317 in psoriasis and expanded patent portfolio for orthopedic and musculoskeletal therapies.

  • Raised $7.2M through direct offerings and repaid all outstanding debt.

  • Received Nasdaq extension to regain compliance for continued listing.

Financial highlights

  • Research and development expenses rose to $7.4M for 2025, up from $4.5M in 2024, mainly due to higher CRO, lab, and personnel costs.

  • General and administrative expenses remained flat at $9.2M year-over-year, with shifts in personnel, professional fees, and reduced offering and insurance expenses.

  • Net loss increased to $18.6M for 2025 from $11.2M in 2024, driven by higher R&D and G&A expenses.

  • Cash and cash equivalents were $4.9M at year-end 2025.

Outlook and guidance

  • Plans to complete manufacturing and site enrollment for CYWC628 in Q1 2026, dose first patient and report interim results in H1 2026, and report final results by year-end 2026.

  • Expects IND clearance for CYPS317 in psoriasis and to submit IND for CYMS101 in multiple sclerosis in H1 2026.

  • Plans to amend IND for degenerative disc disease by end of 2026.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next FibroBiologics earnings date

Logotype for FibroBiologics Inc
Q1 202613 May, 2026
FibroBiologics
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next FibroBiologics earnings date

Logotype for FibroBiologics Inc
Q1 202613 May, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

FibroBiologics Inc. is a biotechnology company that specializes in regenerative medicine and cell therapy. The company is focused on developing innovative treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds over 150 U.S. and international patents and patents pending, covering various clinical pathways including orthopedics, multiple sclerosis, psoriasis, wound healing, and cancer. The company is headquartered in Houston, Texas, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage